Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Malignant Neoplasms
|
1641 | 0.574 | 0.680 | 11 | 111511840 | intron variant | T/C | snv | 0.32 | 0.100 | 0.846 | 13 | 2014 | 2019 | |||||
Liver carcinoma
|
942 | 0.574 | 0.680 | 11 | 111511840 | intron variant | T/C | snv | 0.32 | 0.100 | 0.750 | 12 | 2011 | 2018 | |||||
Primary malignant neoplasm
|
1374 | 0.574 | 0.680 | 11 | 111511840 | intron variant | T/C | snv | 0.32 | 0.100 | 0.833 | 12 | 2014 | 2019 | |||||
Colorectal Carcinoma
|
1962 | 0.574 | 0.680 | 11 | 111511840 | intron variant | T/C | snv | 0.32 | 0.070 | 0.857 | 7 | 2013 | 2019 | |||||
Squamous cell carcinoma of esophagus
|
329 | 0.574 | 0.680 | 11 | 111511840 | intron variant | T/C | snv | 0.32 | 0.060 | 1.000 | 6 | 2013 | 2019 | |||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.574 | 0.680 | 11 | 111511840 | intron variant | T/C | snv | 0.32 | 0.040 | 0.750 | 4 | 2014 | 2018 | |||||
Malignant neoplasm of stomach
|
615 | 0.574 | 0.680 | 11 | 111511840 | intron variant | T/C | snv | 0.32 | 0.040 | 0.750 | 4 | 2014 | 2019 | |||||
Stomach Carcinoma
|
652 | 0.574 | 0.680 | 11 | 111511840 | intron variant | T/C | snv | 0.32 | 0.040 | 0.750 | 4 | 2014 | 2019 | |||||
Acute lymphocytic leukemia
|
222 | 0.574 | 0.680 | 11 | 111511840 | intron variant | T/C | snv | 0.32 | 0.030 | 1.000 | 3 | 2016 | 2019 | |||||
Adult Hepatocellular Carcinoma
|
14 | 0.574 | 0.680 | 11 | 111511840 | intron variant | T/C | snv | 0.32 | 0.020 | 0.500 | 2 | 2014 | 2015 | |||||
Breast Carcinoma
|
2793 | 0.574 | 0.680 | 11 | 111511840 | intron variant | T/C | snv | 0.32 | 0.020 | 1.000 | 2 | 2013 | 2014 | |||||
Carcinogenesis
|
355 | 0.574 | 0.680 | 11 | 111511840 | intron variant | T/C | snv | 0.32 | 0.020 | 1.000 | 2 | 2016 | 2017 | |||||
Central neuroblastoma
|
231 | 0.574 | 0.680 | 11 | 111511840 | intron variant | T/C | snv | 0.32 | 0.020 | 1.000 | 2 | 2019 | 2019 | |||||
Childhood Acute Lymphoblastic Leukemia
|
261 | 0.574 | 0.680 | 11 | 111511840 | intron variant | T/C | snv | 0.32 | 0.020 | 1.000 | 2 | 2016 | 2016 | |||||
Childhood Hepatocellular Carcinoma
|
17 | 0.574 | 0.680 | 11 | 111511840 | intron variant | T/C | snv | 0.32 | 0.020 | 0.500 | 2 | 2014 | 2015 | |||||
Childhood Neuroblastoma
|
231 | 0.574 | 0.680 | 11 | 111511840 | intron variant | T/C | snv | 0.32 | 0.020 | 1.000 | 2 | 2019 | 2019 | |||||
Coronary heart disease
|
1178 | 0.574 | 0.680 | 11 | 111511840 | intron variant | T/C | snv | 0.32 | 0.020 | 0.500 | 2 | 2013 | 2019 | |||||
Esophageal carcinoma
|
272 | 0.574 | 0.680 | 11 | 111511840 | intron variant | T/C | snv | 0.32 | 0.020 | 1.000 | 2 | 2013 | 2018 | |||||
Esophageal Neoplasms
|
270 | 0.574 | 0.680 | 11 | 111511840 | intron variant | T/C | snv | 0.32 | 0.020 | 1.000 | 2 | 2013 | 2018 | |||||
Malignant neoplasm of breast
|
3417 | 0.574 | 0.680 | 11 | 111511840 | intron variant | T/C | snv | 0.32 | 0.020 | 1.000 | 2 | 2013 | 2014 | |||||
Malignant neoplasm of esophagus
|
214 | 0.574 | 0.680 | 11 | 111511840 | intron variant | T/C | snv | 0.32 | 0.020 | 1.000 | 2 | 2013 | 2018 | |||||
Malignant neoplasm of gastrointestinal tract
|
55 | 0.574 | 0.680 | 11 | 111511840 | intron variant | T/C | snv | 0.32 | 0.020 | 1.000 | 2 | 2015 | 2019 | |||||
Malignant neoplasm of liver
|
88 | 0.574 | 0.680 | 11 | 111511840 | intron variant | T/C | snv | 0.32 | 0.020 | 0.500 | 2 | 2014 | 2015 | |||||
Malignant neoplasm of prostate
|
1082 | 0.574 | 0.680 | 11 | 111511840 | intron variant | T/C | snv | 0.32 | 0.020 | 1.000 | 2 | 2017 | 2019 | |||||
Nasopharyngeal carcinoma
|
320 | 0.574 | 0.680 | 11 | 111511840 | intron variant | T/C | snv | 0.32 | 0.020 | 1.000 | 2 | 2013 | 2014 |